Criterion Application Pharmacotherapeutics Assignment Help: How to Answer This Question
This type of question evaluates analytical and critical thinking skills.
What This Question Is About
This question relates to criterion application pharmacotherapeutics and requires a structured academic response.
How to Approach This Question
Use appropriate theories and support your answer with clear reasoning.
Key Explanation
This topic involves criterion application pharmacotherapeutics. A strong answer should include explanation, application, and examples.
Original Question
Criterion 2. Application of pharmacotherapeutics to inform safe medication practice, specific to medication administration, and in relation to person centred-care Students are to respond to the questions in the case study that align with the Clinical Reasoning Cycle. Students are to use the questions to guide them within the case study to explain the pathophysiological processes of the disease relating to the patient context and the associated medication regimens. They are then to cover aspects of pharmacotherapeutics that demonstrate their understanding of general concepts and principles of medication administration in response to person-centred care Q4. Mr Barrett is prescribed 2 litres of oxygen via nasal prongs continuously. What are the important nursing considerations when administering oxygen to patients with COPD? (approx. 150 words) 12 marks • WHO Global Patient Safety Challenge – Medication without harm would be a good resource to use when looking at person-centred care and safe medication practice. • Health literacy – what important aspects of oxygen would Mr Barrett need to be aware of as a patient with COPD? • What happens with ventilation and perfusion (gas exchange)? • What happens to the respiratory centre of patients with COPD over time?
******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."
